Masahiko Ohtsuki
Director/Board Member at DAIICHI SANKYO CO., LTD.
Network origin in Masahiko Ohtsuki first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 48 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Masahiko Ohtsuki via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Tokyo | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| University of Hitotsubashi | College/University | Undergraduate Degree | |
| Daiichi Sankyo Biotech Co. Ltd. | Chairman | ||
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
| FUJIMORI KOGYO CO., LTD. | Industrial Specialties | Director/Board Member | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
| Tokyo Medical & Dental University | College/University | Doctorate Degree | |
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member | |
| Osaka University | College/University | Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Sumitomo Life Insurance Co.
 Sumitomo Life Insurance Co. Life/Health InsuranceFinance Sumitomo Life Insurance Co. engages in the provision of life insurance services. It also sells investment trust and manages defined contribution pension plans. The company was founded in May 1907 and is headquartered in Osaka, Japan. | Life/Health Insurance | Director/Board Member | |
| The Society of Japanese Aerospace Companies | Chairman | ||
| Japan Vocational Ability Development Association | Chairman | ||
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Merck Vaccine Division | Compliance Officer | ||
| University of San Diego | College/University | Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree | |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Compliance Officer | |
Sankyo Pharma GmbH
 Sankyo Pharma GmbH Medical DistributorsDistribution Services Part of Daiichi Sankyo Co., Ltd., Sankyo Pharma GmbH is a German pharmaceutical distribution company. The company is based in Munich, Germany. Jan van Ruymbeke has been the CEO of the company since 2012. | Medical Distributors | Chairman | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd.
 Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is based in Beijing, China. Part of Fosun International Holdings Ltd., Daiichi Sankyo Pharmaceutical (Beijing) Co. Ltd. is a Chinese company that manufactures and markets pharmaceuticals. The company was founded in 1998. Daiichi Sankyo Pharmaceutical (Beijing) Co. was acquired by Chongqing Yao Pharmaceutical Co., Ltd. from Daiichi Sankyo Co., Ltd. on August 31, 2022. | Pharmaceuticals: Major | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Connecticut | College/University | Corporate Officer/Principal |
Statistics
International
| United States | 27 |
| Japan | 17 |
| Switzerland | 3 |
| India | 2 |
| Vietnam | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 6 |
| Health Services | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 95 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 28 |
| Chairman | 23 |
| President | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Sukumar Nagendran | 15 |
| Kazuaki Kama | 15 |
| Sawako Nohara | 13 |
| Kunio Ishihara | 10 |
| Takashi Okimoto | 10 |
| Hiroshi Hirabayashi | 10 |
| Antoine Yver | 9 |
| Tsuguya Fukui | 7 |
| Jay Feingold | 7 |
| Naoki Adachi | 6 |
| Susan Romanus | 6 |
| Hiroshi Toda | 6 |
| Noritaka Uji | 6 |
| Yoshifumi Nishikawa | 6 |
| Joji Nakayama | 5 |
- Stock Market
- Insiders
- Masahiko Ohtsuki
- Company connections
